1000Farmacie Secures $25 Million in Series A Funding


The Healthware Ventures portfolio company 1000Farmacie, a leading Italian e-pharmacy marketplace, has announced the successful completion of its second tranche of Series A funding, raising a total of $25 million.

Founded by Nicolo Petrone (CEO), Mohamed Younes (COO), and Alberto Marchetti (CMO) in 2020, 1000Farmacie now has over 500,000 active clients and annualised sales of over $55 million, becoming one of the key industry players.

The company secured an additional $10 million in the extension round, having secured $15 million initially in 2022 – highlighting investor confidence and further accelerating 1000Farmacie’s mission to revolutionise the pharmaceutical industry.

Prominent investors such as GG 1978, P101 (with its funds P102 and ITA 500 – Azimut), HBM Healthcare Investments, LIFTT, IAG, Club degli Investitori, and Healthware Ventures participated in the funding round, underscoring a belief in 1000Farmacie’s vision and potential for growth.

A key focus of 1000Farmacie's expansion strategy is the Italian prescription (RX) market, particularly the provision of an innovative home delivery service tailored to chronic patients. By leveraging cutting-edge technology, the company aims to enhance accessibility, convenience, and patient care in the sector.

"With this second tranche of Series A funding, 1000Farmacie is well-positioned to revolutionise the way pharmaceutical services are delivered in Italy," said Nicolo Petrone. "We are committed to leveraging our innovative home delivery service to empower chronic patients with convenient access to their prescriptions, thereby enhancing their overall quality of life."

1000Farmacie's innovative approach has already garnered recognition within the industry, with notable partnerships and collaborations on the horizon. The company remains committed to forging strategic alliances to enhance its service offering and accelerate its growth trajectory and path to profitability.